Comprehensive Geriatric Assessment (CGA) in qualification for palliative chemotherapy

Autor: Jadwiga Jośko-Ochojska, Grzegorz Słomian, Katarzyna Kryszczyszyn-Musialik

Publikováno v: OncoReview. 9:64-67

More than a half of new cancer cases affects elderly people. The number of patients in that group is constantly raising. Geriatric patients with cancer are very ununiform group with their biological age, comorbidities and conditions. The risk of the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c0cbc67985e06be452d5feaba3dd0f85
https://doi.org/10.24292/01.or.319260619

The role of adiponectin and leptin in the treatment of ovarian cancer patients

Autor: Wojciech Roczniak, Szymon P Słomian, Marta Buczkowska, Anna Głogowska-Gruszka, Szymon Janyga, Damian Nowak, Przemysław Nowak, Grzegorz Słomian

Publikováno v: Endokrynologia Polska. 70:57-63

Introduction: Ovarian cancer is most frequently detected in the advanced stage. Although its pathogenesis is not fully elucidated, it is assumed that body susceptibility and hormonal disorders are responsible. The role of some cytokines as predictors

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d458ee3f17748a800aeb1fa7ea91ccd
https://doi.org/10.5603/ep.a2018.0081

Skin toxicity in BRAF(V600) mutated metastatic cutaneous melanoma patients treated with vemurafenib

Autor: Grzegorz Słomian, Joanna Huszno, Elżbieta Nowara, Jaroslaw Nieckula

Publikováno v: Advances in Dermatology and Allergology, Vol 33, Iss 1, Pp 52-56 (2016)
Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii

Introduction: The use of orally available BRAF kinase inhibitor – vemurafenib is associated with numerous adverse skin reactions. Aim: To assess the safety and early side effects of vemurafenib treatment in the unselected group of patients treated

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eec8c9a04cae73e1bcb12abb73ff8ef
https://www.termedia.pl/Skin-toxicity-in-BRAF-V600-mutated-metastatic-cutaneous-melanoma-patients-treated-with-vemurafenib,7,24295,1,1.html

Acute decompensated heart failure as a reason of premature chemotherapy discontinuation may be independent of a lifetime doxorubicin dose in lymphoma patients with cardiovascular disorders

Autor: Grzegorz Charliński, Wanda Knopinska-Posluszny, Grzegorz Słomian, Monika Długosz-Danecka, Wojciech Jurczak, Sebastian Szmit, Jan Maciej Zaucha, Joanna Drozd-Sokołowska, Beata Kumiega, Marta Morawska, Barbara Sosnowska-Pasiarska, Monika Joks, Ewa Chmielowska, Wojciech Spychałowicz

Background Algorithm of anthracycline-based chemotherapy with favourable cardio-oncological outcome should be clearly re-defined for lymphoma patients with significant pre-existing cardiovascular diseases. A clinical benefit of liposomal forms of ant

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84f5efaaf78a216346ec08bed5c7740a
https://ruj.uj.edu.pl/xmlui/handle/item/96103

Histamine H3 receptor ligands modulate L-dopa-evoked behavioral responses and L-dopa-derived extracellular dopamine in dopamine-denervated rat striatum

Autor: Richard M. Kostrzewa, Izabela Biedka, Joanna Dabrowska, Przemysław Nowak, Wojciech Roczniak, Grzegorz Słomian, Aleksandra Bortel, Ryszard Brus

Publikováno v: Neurotoxicity Research. 13:231-240

To explore a recently established association between histaminergic and dopaminergic neuronal phenotypic systems in brain, we determined the effect of the respective histaminergic H(3) receptor agonist and antagonist/inverse agonist, imetit and thiop

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4b9f2b6ad2e6d1ce81303f20030bbca
https://doi.org/10.1007/bf03033506